These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 23732755)
21. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490 [TBL] [Abstract][Full Text] [Related]
22. Prospective Randomized Evaluation of Implantable Cardioverter-Defibrillator Programming in Patients With a Left Ventricular Assist Device. Richardson TD; Hale L; Arteaga C; Xu M; Keebler M; Schlendorf K; Danter M; Shah A; Lindenfeld J; Ellis CR J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29475875 [TBL] [Abstract][Full Text] [Related]
23. Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy. Gronda E; Genovese S; Padeletti L; Cacciatore F; Vitale DF; Bragato R; Innocenti L; Schiano C; Sommese L; De Pascale MR; Genovese L; Abete P; Donatelli F; Napoli C Cardiol J; 2015; 22(4):459-66. PubMed ID: 26325259 [TBL] [Abstract][Full Text] [Related]
24. Hospital-based and telemonitoring guided home-based training programs: effects on exercise tolerance and quality of life in patients with heart failure (NYHA class III) and cardiac resynchronization therapy. A randomized, prospective observation. Smolis-Bąk E; Dąbrowski R; Piotrowicz E; Chwyczko T; Dobraszkiewicz-Wasilewska B; Kowalik I; Kazimierska B; Jędrzejczyk B; Smolis R; Gepner K; Maciąg A; Sterliński M; Szwed H Int J Cardiol; 2015 Nov; 199():442-7. PubMed ID: 26276068 [TBL] [Abstract][Full Text] [Related]
25. Sustained clinical benefit of cardiac resynchronization therapy in non-LBBB patients with prolonged PR-interval: MADIT-CRT long-term follow-up. Stockburger M; Moss AJ; Klein HU; Zareba W; Goldenberg I; Biton Y; McNitt S; Kutyifa V Clin Res Cardiol; 2016 Nov; 105(11):944-952. PubMed ID: 27318807 [TBL] [Abstract][Full Text] [Related]
26. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. Young JB; Abraham WT; Smith AL; Leon AR; Lieberman R; Wilkoff B; Canby RC; Schroeder JS; Liem LB; Hall S; Wheelan K; JAMA; 2003 May; 289(20):2685-94. PubMed ID: 12771115 [TBL] [Abstract][Full Text] [Related]
27. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy. Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089 [TBL] [Abstract][Full Text] [Related]
28. The Registry Evaluating Functional Outcomes of Resynchronization Management (REFORM): quality of life and psychological functioning in patients receiving cardiac resynchronization therapy. Ford J; Sears S; Ramza B; Reynolds DW; Nguyen P; Fedewa M; House J; Kennedy P; Thompson R; Murray C J Cardiovasc Electrophysiol; 2014 Jan; 25(1):43-51. PubMed ID: 24102945 [TBL] [Abstract][Full Text] [Related]
29. Predictors for early mortality and arrhythmic events in patients with cardiac resynchronization therapy with defibrillator: A two center cohort study. Gunten SV; Theuns DA; Kühne M; Reichlin T; Sticherling C; Schaer B Cardiol J; 2019; 26(6):711-716. PubMed ID: 30484267 [TBL] [Abstract][Full Text] [Related]
30. Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry. Zusterzeel R; Spatz ES; Curtis JP; Sanders WE; Selzman KA; Piña IL; Bao H; Ponirakis A; Varosy PD; Masoudi FA; Caños DA; Strauss DG Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S4-11. PubMed ID: 25714821 [TBL] [Abstract][Full Text] [Related]
31. The prognostic benefit of cardiac resynchronization therapy is greater in concordant vs. discordant left bundle branch block in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Padeletti L; Aimo A; Vishenvsky B; Schwartz A; McNitt S; Wang PJ; Moss AJ; Emdin M; Zareba W Europace; 2018 May; 20(5):794-800. PubMed ID: 28398490 [TBL] [Abstract][Full Text] [Related]
32. Cardiac resynchronization therapy improves psycho-cognitive performance in patients with heart failure. Duncker D; Friedel K; König T; Schreyer H; Lüsebrink U; Duncker M; Oswald H; Klein G; Gardiwal A Europace; 2015 Sep; 17(9):1415-21. PubMed ID: 25745071 [TBL] [Abstract][Full Text] [Related]
33. Gender disparities in quality of life and psychological disturbance in patients with implantable cardioverter-defibrillators. Rahmawati A; Chishaki A; Sawatari H; Tsuchihashi-Makaya M; Ohtsuka Y; Nakai M; Miyazono M; Hashiguchi N; Sakurada H; Takemoto M; Mukai Y; Inoue S; Sunagawa K; Chishaki H Circ J; 2013; 77(5):1158-65. PubMed ID: 23337265 [TBL] [Abstract][Full Text] [Related]
34. Complete left bundle branch block and smaller left atrium are predictors of response to cardiac resynchronization therapy in advanced heart failure. Imamura T; Kinugawa K; Nitta D; Komuro I Circ J; 2015; 79(11):2414-21. PubMed ID: 26376671 [TBL] [Abstract][Full Text] [Related]
35. Effectiveness of a comprehensive interactive eHealth intervention on patient-reported and clinical outcomes in patients with an implantable cardioverter defibrillator [ACQUIRE-ICD trial]: study protocol of a national Danish randomised controlled trial. Pedersen SS; Skovbakke SJ; Wiil UK; Schmidt T; dePont Christensen R; Brandt CJ; Sørensen J; Vinther M; Larroudé CE; Melchior TM; Riahi S; Smolderen KGE; Spertus JA; Johansen JB; Nielsen JC BMC Cardiovasc Disord; 2018 Jul; 18(1):136. PubMed ID: 29969990 [TBL] [Abstract][Full Text] [Related]
36. Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database. Lunati M; Proclemer A; Boriani G; Landolina M; Locati E; Rordorf R; Daleffe E; Ricci RP; Catanzariti D; Tomasi L; Gulizia M; Baccillieri MS; Molon G; Gasparini M; Europace; 2016 Sep; 18(9):1391-8. PubMed ID: 26826135 [TBL] [Abstract][Full Text] [Related]
37. Risk of Ventricular Tachyarrhythmic Events in Patients Who Improved Beyond Guidelines for a Defibrillator in MADIT-CRT. Sherazi S; Shah F; Kutyifa V; McNitt S; Aktas MK; Polonsky B; Zareba W; Goldenberg I JACC Clin Electrophysiol; 2019 Oct; 5(10):1172-1181. PubMed ID: 31648742 [TBL] [Abstract][Full Text] [Related]
38. Cost-Effectiveness of Adding Cardiac Resynchronization Therapy to an Implantable Cardioverter-Defibrillator Among Patients With Mild Heart Failure. Woo CY; Strandberg EJ; Schmiegelow MD; Pitt AL; Hlatky MA; Owens DK; Goldhaber-Fiebert JD Ann Intern Med; 2015 Sep; 163(6):417-26. PubMed ID: 26301323 [TBL] [Abstract][Full Text] [Related]
39. Exercise training and cardiac rehabilitation in patients with implantable cardioverter defibrillators: a review of current literature focusing on safety, effects of exercise training, and the psychological impact of programme participation. Isaksen K; Morken IM; Munk PS; Larsen AI Eur J Prev Cardiol; 2012 Aug; 19(4):804-12. PubMed ID: 22988593 [TBL] [Abstract][Full Text] [Related]
40. [Quality of life in patients after anti-arrhythmic devices implantation]. Lełakowska-Piela M; Pudło J; Rydlewska A; Senderek T; Lelakowski J Pol Merkur Lekarski; 2013 Dec; 35(210):331-8. PubMed ID: 24490461 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]